Our strategy and vision

Creating opportunities for a positive future

Neuropharm is focused on helping people with unmet medical needs enjoy a better quality of life.

We describe our approach as “From Patient to Product”. This means we use our scientific and biological understanding of disorders of the central nervous system and contacts with the patient and physician communities, to track back to existing compounds or products that could benefit patients affected by Autism or other neurodevelopmental conditions.

We concentrate on selected developmental disorders where few or no existing medicines have been approved by the FDA or EMEA, and on niche markets with defined patient populations with unmet medical needs.

The group’s vision is to become the partner of choice for clinicians and patient advocacy organizations working in the field of Autism and other neurodevelopmental disorders, and to develop effective therapies for these conditions which offer significant benefits for physicians, healthcare providers and patients alike.

We also see the development of products that represent cost-effective solutions as an imperative element to ensure future patient access.